183 related articles for article (PubMed ID: 3323563)
21. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
Mahoney DH; Shuster J; Nitschke R; Lauer SJ; Winick N; Steuber CP; Camitta B
J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
[TBL] [Abstract][Full Text] [Related]
22. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
[TBL] [Abstract][Full Text] [Related]
23. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
24. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
25. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
[TBL] [Abstract][Full Text] [Related]
26. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of acute childhood leukemia. A new protocol 811 for the high risk group of acute lymphocytic leukemia (Phase III study)].
Mimaya J; Fujimoto T; Hiyoshi Y; Yanai M; Komazawa M; Sekine I; Koizumi S; Nishikawa K; Higashi O; Utsumi J
Rinsho Ketsueki; 1984 Aug; 25(8):1190-6. PubMed ID: 6392601
[No Abstract] [Full Text] [Related]
28. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.
Brandalise SR; Pinheiro VR; Aguiar SS; Matsuda EI; Otubo R; Yunes JA; Pereira WV; Carvalho EG; Cristofani LM; Souza MS; Lee ML; Dobbin JA; Pombo-de-Oliveira MS; Lopes LF; Melnikoff KN; Brunetto AL; Tone LG; Scrideli CA; Morais VL; Viana MB
J Clin Oncol; 2010 Apr; 28(11):1911-8. PubMed ID: 20212252
[TBL] [Abstract][Full Text] [Related]
29. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
van der Werff Ten Bosch J; Suciu S; Thyss A; Bertrand Y; Norton L; Mazingue F; Uyttebroeck A; Lutz P; Robert A; Boutard P; Ferster A; Plouvier E; Maes P; Munzer M; Plantaz D; Dresse MF; Philippet P; Sirvent N; Waterkeyn C; Vilmer E; Philippe N; Otten J
Leukemia; 2005 May; 19(5):721-6. PubMed ID: 15744348
[TBL] [Abstract][Full Text] [Related]
30. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
[TBL] [Abstract][Full Text] [Related]
31. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84. Report to the Council by the Working Party on Leukaemia in Childhood.
Lancet; 1986 Feb; 1(8478):408-11. PubMed ID: 2868339
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid receptors and steroid sensitivity of human acute lymphoblastic leukemia.
Iacobelli S; Marchetti P; De Rossi G; Mandelli F
Prog Clin Biol Res; 1984; 142():235-46. PubMed ID: 6584926
[No Abstract] [Full Text] [Related]
33. [Analysis of advances in the treatment of lymphoblastic leukemia].
Korczowski R; Jakieła T
Pediatr Pol; 1985 Jan; 60(1):15-9. PubMed ID: 3862055
[No Abstract] [Full Text] [Related]
34. [Treatment of acute childhood leukemia. A new protocol 811 for the standard risk group of acute lymphocytic leukemia (Phase III study)].
Koizumi S; Fujimoto T; Higashi O; Utsumi J; Mimaya J; Sekine I; Shike S; Imashuku S; Yamamoto S; Ninomiya T
Rinsho Ketsueki; 1983 Dec; 24(12):1633-40. PubMed ID: 6368900
[No Abstract] [Full Text] [Related]
35. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
36. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
[TBL] [Abstract][Full Text] [Related]
37. [Results of 2 protocols in the treatment of acute lymphoid leukemia in children, according to prognostic factors].
Misset JL; Gil-Delgado MA; Delgado M; de Vassal F; Machover D; Goutner A; Mathé G
Rev Esp Oncol; 1982; 29(4):785-801. PubMed ID: 6965045
[TBL] [Abstract][Full Text] [Related]
38. [Results of acute lymphoblastic leukemia treatment in children. (Apropos of 58 cases)].
Goudemand M; Bauters F; Lerche B
Lille Med; 1972 Feb; 17(2):220-7. PubMed ID: 4504533
[No Abstract] [Full Text] [Related]
39. High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study.
Frankel LS; Wang YM; Shuster J; Nitschke R; Doering EJ; Pullen J
J Clin Oncol; 1983 Dec; 1(12):804-9. PubMed ID: 6583318
[TBL] [Abstract][Full Text] [Related]
40. Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
Toyoda Y; Manabe A; Tsuchida M; Hanada R; Ikuta K; Okimoto Y; Ohara A; Ohkawa Y; Mori T; Ishimoto K; Sato T; Kaneko T; Maeda M; Koike Ki; Shitara T; Hoshi Y; Hosoya R; Tsunematsu Y; Bessho F; Nakazawa S; Saito T
J Clin Oncol; 2000 Apr; 18(7):1508-16. PubMed ID: 10735899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
